The global Human Platelet Lysate (HPL) Market is expected to see significant growth in 2024, driven by advancements in biotechnology, regenerative medicine, and increased demand for high-quality serum alternatives in cell culture. HPL, a blood-derived product rich in growth factors, is increasingly recognized for its ability to enhance cell proliferation, differentiation, and tissue regeneration. Its applications across the healthcare and pharmaceutical sectors, particularly in stem cell research and regenerative medicine, have positioned it as a valuable tool in modern medical treatments.